Language: English

SEARCH

LATEST NEWS

  • January - Private health insurer CIGNA, now providing full coverage of Actifit in the UK.

    Orteq signs sales agreement with Optimum Orthopaedics to sell Actifit in Greece.

  • February - Orteq platinum sponsor at the Meniscus Cradle to Rocker meeting in Gent Feb 4th-6th. Sign up at the exhibition booth for the training workshop on Saturday 6th afternoon.

    Orteq attends the ACL study group meeting in Thailand, Feb 20th.

  • March - Sign up for the next UK Actifit / North Star training workshop with Tim Spalding/ Peter Verdonk on March 18th at Walsgrave hospital.

    Latest Actifit EU clinical data presented at BASK, Oxford Mar 25th by Dr Peter Verdonk.

    The Actifit training workshop in Frankfurt on March 24th/25th is now full.

Terms and conditions

Home

 

Orteq Bioengineering is a world leader in the field of biodegradable, polymer technology.

We create innovative healthcare products that encourage the body’s own natural healing process. Our implants promote the in-growth of new tissue in areas of the body where damaged tissue cannot regenerate. As the damaged tissue heals, the implant gradually dissolves and is removed naturally from the body.

We are very proud of (our) first product, Actifit™. It was specifically designed to help surgeons repair meniscus tears through key-hole (arthroscopic) surgery.

One of orthopaedic sports medicine’s biggest problems is repairing a damaged meniscus. Each year, there are about 1.5 million cases of meniscal tears in Western Europe and the United States. ActiFit, our new meniscus repair product addresses this substantial unmet medical need. After successful clinical trials, Actifit™ received its CE Mark in 2008 and is now available throughout Europe.